Recap of the 2025 Jackson Hole Economic Symposium

The 2025 Federal Reserve Jackson Hole Economic Policy Symposium, themed “Labour Markets in Transition: Demographics, Productivity and Macroeconomic Policy,” brought together central bankers, economists and policymakers to assess the long-term shifts shaping the global economy. While near-term inflation management remains a focus, discussions highlighted how demographic change, technological advances and evolving workforce dynamics are reshaping the policy landscape.


The US economy has displayed resilience this year. Inflation has eased from its post-pandemic highs, while employment remains near maximum levels despite tighter immigration policies and slower labour force growth. These conditions framed the symposium’s central theme: how structural transitions in labour markets and productivity will influence growth, inflation and policy in the coming decade.


Federal Reserve Chair Jerome Powell’s keynote attracted the most attention. He acknowledged the progress made in bringing inflation down but warned that the path ahead remains uncertain. Goods prices have stabilised, yet services inflation, particularly in housing and healthcare, continues to run above target. Wage growth, although moderating, remains higher than levels consistent with the Fed’s 2% inflation goal. Powell reiterated that policy will stay restrictive until there is stronger evidence that inflation is firmly on a sustainable path lower. He stressed that acting too early risks reversing hard-won progress, but he also left open the door for adjustments if growth slows more sharply than expected. Markets had anticipated a faster pace of easing, but Powell’s remarks shifted expectations towards a slower and more conditional approach, with futures pricing now pointing to a more measured pace of cuts through 2025.





A notable development was the Fed’s update to its monetary policy framework following a five-year review. The revisions included moving away from the “effective lower bound” as a central focus, reflecting today’s higher interest rate environment, and dropping the earlier “makeup” strategy of targeting moderate inflation overshoots. The Fed reaffirmed its flexible inflation-targeting framework and its dual mandate of maximum employment and price stability. It also clarified that employment can exceed estimates of sustainable levels without automatically triggering policy tightening, highlighting a more balanced and data-driven approach.


Beyond Powell’s remarks, the symposium explored how demographic and productivity trends are reshaping the macroeconomic outlook. Ageing populations and slowing labour force participation in advanced economies are expected to weigh on potential growth and place greater pressure on public finances. At the same time, the productivity outlook remains uncertain. Some argued that advances in automation and digital technologies could deliver gains that offset demographic headwinds, while others pointed to weaker investment and innovation as possible constraints. These uncertainties reduce the margin for error in monetary and fiscal policy and suggest that central banks will have to operate in a more constrained environment in the years ahead.


The global policy backdrop also featured prominently. European policymakers stressed the challenge of stimulating growth in a low-demand environment, while Japan outlined its gradual move away from ultra-loose policy as domestic wage and price pressures become more entrenched. Emerging market participants highlighted the difficulties of managing capital flows and debt burdens in a world of higher US rates and a strong dollar. The divergence of policy paths underscores that global monetary conditions will not move in lockstep, creating a more fragmented investment environment.


For investors, the message from Jackson Hole was twofold. In the near term, the Fed’s stance suggests that interest rates will remain restrictive for longer than markets had hoped, limiting the scope for a sharp rebound in valuations. Longer term, structural forces such as demographics and productivity will shape inflation, growth and policy trajectories. Equity strategies may need to balance exposure to innovation-driven growth sectors with defensives and dividend payers. In fixed income, shorter-duration securities offer attractive carry in a higher-for-longer environment, while credit markets may face renewed pressures if growth slows. Currency markets are likely to see more volatility as policy divergence across regions deepens.


The symposium reinforced that while the battle against inflation is ongoing, longer-term transitions in labour markets and productivity are already reshaping the policy environment. From an investment standpoint, flexibility and careful portfolio positioning remain essential, with an emphasis on balancing cyclical risks with the structural forces that will define the coming decade.

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Is a Share Advisor

right for you?

May 6, 2026
The RBA has lifted rates to 4.35%. Here’s what it means for households, inflation, markets, sector performance and the outlook for Australian investors.
May 6, 2026
About The a2 Milk Co Ltd The a2 Milk Company Limited, together with its subsidiaries, sells A2-type protein type branded milk and related products in Australia, New Zealand, China, rest of Asia, and the United States. The company offers infant milk formula; other nutritional products and milk; manufactures and sells nutritional and ingredients products, as well as provides rent, royalty, and licensing services. It offers its products under the a2 Milk and a2 Platinum brands. The company was formerly known as A2 Corporation Limited and changed its name to The a2 Milk Company Limited in April 2014. The a2 Milk Company Limited was incorporated in 2000 and is based in Auckland, New Zealand. Source: EODHD Key Stats
May 5, 2026
About Meta Platforms Inc Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality (VR) headsets, and AI glasses in the United States, Canada, Europe, Asia-Pacific, and internationally. It operates through two segments, Family of Apps (FoA) and Reality Labs (RL). The FoA segment offers Facebook, which enables people to build community through feed, reels, stories, groups, marketplace, and other; Instagram that brings people closer through Instagram feed, stories, reels, live, and messaging; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; Meta AI, an assistant that's available across apps, as a stand-alone app, on AI glasses, and on the web; Threads, an application for text-based updates and public conversations; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact in a private way. The RL segment provides virtual and augmented reality products, including consumer hardware, software, and content that help people feel connected anytime and anywhere, as well as Meta Quest devices that enable social experiences across gaming, fitness, entertainment, and more. The segment also includes wearables such as AI glasses like Ray Ban Meta and Oakley Meta glasses, featuring Meta AI for advanced conversational and hands free interaction; and the Meta Ray Ban Display, which combines AI glasses with an integrated lens display and the Meta Neural Band, a wrist worn device using electromyography that lets people control their AI glasses through neuromuscular signals. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. The company was incorporated in 2004 and is headquartered in Menlo Park, California. Source:EODHD Key Stats
May 5, 2026
About Amazon.com Inc Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, fire tablets, fire TVs, echo, ring, blink, and eero; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, Artificial intelligence, database, analytics, machine learning, and other services, as well as advertising services through programs, such as sponsored ads, display, and video advertising. Additionally, the company offers Amazon Prime, a membership program. The company's products offered through its stores include merchandise and content purchased for resale and products offered by third-party sellers. It serves consumers, sellers, developers, enterprises, content creators, advertisers, and employees. The company was incorporated in 1994 and is headquartered in Seattle, Washington. Source:EODHD Key Stats
May 1, 2026
Earnings may beat expectations, but guidance drives markets. Learn how to read forward outlooks, tone and signals to better interpret stock price reactions.
May 1, 2026
About Visa Inc. Visa Inc. operates as a payment technology company in the United States and internationally. The company operates VisaNet, a transaction processing network that enables authorization, clearing, and settlement of payment transactions. It also offers credit, debit, and prepaid card products; tap to pay, tokenization, and click to pay services; Visa Direct, a solution that facilitates the delivery of funds to eligible cards, bank accounts, and digital wallets; Visa B2B Connect, a multilateral business-to-business cross-border payments network; Visa Cross-Border Solution, a cross-border consumer payments solution; and Visa DPS that provides a range of value-added services, including fraud mitigation, dispute management, data analytics, campaign management, a suite of digital solutions, and contact center services. The company also provides acceptance solutions, which include Cybersource and Authorize.net that provides new and enhanced payment integrations with ecommerce platforms, enabling sellers and acquirers to offer tailored commerce experiences; risk and identity solutions, such as Visa Advanced Authorization, Visa Secure, Visa Consumer Authentication Service, Visa Protect Authentication Intelligence, and Visa Provisioning Intelligence; and Visa Consulting and Analytics, a payment consulting advisory services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brands. The company serves merchants, financial institutions, and government entities. Visa Inc. was founded in 1958 and is headquartered in San Francisco, California. Source:EODHD Key Stats
May 1, 2026
About Telix Pharmaceuticals Ltd Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer. The company develops TLX250, an rADC for treating advanced metastatic kidney cancer; TLX101, a systemic therapy for the treatment of glioblastoma; TLX66, a product candidate for bone marrow conditioning for hematopoietic stem cell transplant conditioning; and Illuccix and Gozellix for the treatment of prostate cancer. The company is also developing TLX592, a prostate cancer therapy candidate for targeted alpha therapy based on its proprietary RADmAb-engineered antibody technology; TLX252 for the treatment of patients with advanced metastatic kidney cancer; TLX400, a bladder fibroblast activation protein for treating various tumors; TLX102, a large amino acid transporter-targeting small molecule-based alpha therapy candidate for the treatment of glioblastoma and multiple myeloma; TLX300 for treating soft tissue sarcoma; and TLX090, a bone-seeking agent for bone metastases and pain palliation. In addition, it is developing BiPASS, which is in Phase 3 clinical trial for prostate cancer diagnosis; AlFluor, a novel PET radiochemistry solution; TLX250-Px, a PET diagnostic imaging agent; and TLX101-Px, a radiolabeled amino acid PET agent. It operates in Australia, Belgium, Canada, the United Kingdom, the United States, and internationally. The company has strategic collaboration with University Hospital Essen. The company was founded in 2015 and is headquartered in North Melbourne, Australia. Source:EODHD Key Stats
April 30, 2026
The UAE leaves OPEC on 1 May. Oil prices did not move. Here is why the near-term calm is masking a structural shift investors should not ignore.
April 29, 2026
Earnings are beating expectations, but the market is cautious. See what S&P 500 Q1 results reveal about market concentration and portfolio positioning.
April 28, 2026
Get the latest on Genesis Minerals Limited (ASX:GMD), including stock performance, technical analysis, forecasts & key insights. See if GMD supports your goals.